For research use only. Not for therapeutic Use.
Trastuzumab MMAE is an antibody-drug conjugate (ADC) composed of an anti-HER2 antibody, conjugated to Monomethyl Auristatin E (MMAE), via a Mc linker. Trastuzumab MMAE has the potential for use in research of solid tumors mainly in HER2-positive breast cancer.
| Catalog Number | I047503 |
| Purity | ≥95% |
| Reference | [1] Abdollahpour-Alitappeh M, et al. J Cell Physiol. 2019 Mar;234(3):2693-2704. |
